These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17343337)

  • 1. Sialylation and fucosylation of cancer-associated prostate specific antigen.
    Kosanović MM; Janković MM
    J BUON; 2005; 10(2):247-50. PubMed ID: 17343337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
    Janković MM; Kosanović MM
    Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
    Llop E; Peracaula R
    Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection.
    Kekki H; Peltola M; van Vliet S; Bangma C; van Kooyk Y; Pettersson K
    Clin Biochem; 2017 Jan; 50(1-2):54-61. PubMed ID: 27818346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
    Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R
    Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.
    Llop E; Ferrer-Batallé M; Barrabés S; Guerrero PE; Ramírez M; Saldova R; Rudd PM; Aleixandre RN; Comet J; de Llorens R; Peracaula R
    Theranostics; 2016; 6(8):1190-204. PubMed ID: 27279911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
    Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I
    Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucose and sialic acid expressions in human seminal fibronectin and α{1} -acid glycoprotein associated with leukocytospermia of infertile men.
    Kratz EM; Faundez R; Katnik-Prastowska I
    Dis Markers; 2011; 31(5):317-25. PubMed ID: 22048274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.
    Przybysz M; Maszczak D; Borysewicz K; Szechiński J; Katnik-Prastowska I
    Glycoconj J; 2007 Dec; 24(9):543-50. PubMed ID: 17610063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples.
    Pihikova D; Kasak P; Kubanikova P; Sokol R; Tkac J
    Anal Chim Acta; 2016 Aug; 934():72-9. PubMed ID: 27506346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features.
    Vierbuchen MJ; Fruechtnicht W; Brackrock S; Krause KT; Zienkiewicz TJ
    Cancer; 1995 Sep; 76(5):727-35. PubMed ID: 8625173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
    J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
    Fukushima K; Satoh T; Baba S; Yamashita K
    Glycobiology; 2010 Jan; 20(4):452-60. PubMed ID: 20008118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.
    Belicky S; Černocká H; Bertok T; Holazova A; Réblová K; Paleček E; Tkac J; Ostatná V
    Bioelectrochemistry; 2017 Oct; 117():89-94. PubMed ID: 28651174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of alpha1-acid glycoprotein and fucosylation in hepatitis B patients provides an insight into pathogenesis.
    Mondal G; Chatterjee U; Das HR; Chatterjee BP
    Glycoconj J; 2009 Dec; 26(9):1225-34. PubMed ID: 19459043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.
    Kanoh Y; Akahoshi T; Ohara T; Ohtani N; Mashiko T; Ohtani S; Egawa S; Baba S
    Anticancer Res; 2002; 22(3):1813-7. PubMed ID: 12168874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum IgG oligosaccharide chains with prostate cancer progression.
    Kanoh Y; Mashiko T; Danbara M; Takayama Y; Ohtani S; Egawa S; Baba S; Akahoshi T
    Anticancer Res; 2004; 24(5B):3135-9. PubMed ID: 15510601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.